peptide igf 1 lr3 IGF-1 - 1mg IGF-1 LR3 1mg Research Peptide

Hammond BR Jr, Wooten BR, Snodderly DM

Nauk Visn Uzhhorod Univ Ser Khim 1:19 Cock IE et al (2022) The feasibility of southern African traditional plant therapies for ophthalmic use

Sedky, D., Ghazy, A

These data support the possibility of local-delivery applications (e.g., topical, inhalation, or GI mucosal targeting) where the short-lived reactive parent compound can act at the site of infection without requiring prolonged systemic exposure (Oluwabusola et al., 2022

Je nach Anwendungshufigkeit etwa 2 bis 3 Monate

Particular attention should be paid to use in infections that could cause severe lung injury, including SARS-CoV-2